Proportion of Patients on Antiplatelets Therapy for Atherosclerotic Cardiovascular Disease Who Have High Bleeding Risk and Are Prescribed a Proton-Pump Inhibitor
Identifying Attributes
Care Settings
Country
Publishing Organisation
Type of Quality Indicator
IOM Quality Dimension
Domain
Defining Attributes
Definition
Proportion of patients on antiplatelets therapy for atherosclerotic cardiovascular disease (ASCVD) who have high bleeding risk and are prescribed a proton-pump inhibitor.
Numerator
Patients on antiplatelets therapy for ASCVD and have high bleeding risk who are prescribed a proton-pump inhibitor.
Denominator
Patients who are on antiplatelets therapy for ASCVD and have high bleeding risk with no contraindication, refusal, or history of intolerance to proton-pump inhibitor.
Exclusions
Use of Risk Adjustment
Risk Adjustments
Stratifications
Collection and Reporting Attributes
Type of Data Collection
Data Collection Methods
Frequency of Data Collection
Frequency of Data Collection in Days
Reporting Methods
Reporting Frequency
Reporting Frequency in Days
Indicator Has Recommended Targets
Source and Reference Attributes
Evidence Source
Aktaa S, Gencer B, Arbelo E, Davos CH, Désormais I, Hollander M, et al. European Society of Cardiology Quality Indicators for Cardiovascular Disease Prevention: developed by the Working Group for Cardiovascular Disease Prevention Quality Indicators in collaboration with the European Association for Preventive Cardiology of the European Society of Cardiology. Eur J Prev Cardiol. 2022;29(7):1060-71.